Turkey · Delayed Price · Currency is TRY IST:SURGY Statistics
Total Valuation
IST:SURGY has a market cap or net worth of TRY 7.70 billion. The enterprise value is 7.55 billion.
| Market Cap | 7.70B |
| Enterprise Value | 7.55B |
Important Dates
The last earnings date was Thursday, September 18, 2025.
| Earnings Date | Sep 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IST:SURGY has 167.50 million shares outstanding. The number of shares has decreased by -6.29% in one year.
| Current Share Class | 165.43M |
| Shares Outstanding | 167.50M |
| Shares Change (YoY) | -6.29% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.04% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 4.58.
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | 4.58 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.89 |
| P/TBV Ratio | 0.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 21.03 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 4.49 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.64, with a Debt / Equity ratio of 0.00.
| Current Ratio | 20.64 |
| Quick Ratio | 1.59 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.08 |
Financial Efficiency
Return on equity (ROE) is 22.71% and return on invested capital (ROIC) is -1.59%.
| Return on Equity (ROE) | 22.71% |
| Return on Assets (ROA) | -1.22% |
| Return on Invested Capital (ROIC) | -1.59% |
| Return on Capital Employed (ROCE) | -1.61% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -696.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.99% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -39.99% |
| 50-Day Moving Average | 56.19 |
| 200-Day Moving Average | 47.69 |
| Relative Strength Index (RSI) | 39.80 |
| Average Volume (20 Days) | 2,434,427 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -189.48M |
| Pretax Income | 986.29M |
| Net Income | 1.68B |
| EBITDA | -187.52M |
| EBIT | -189.48M |
| Earnings Per Share (EPS) | 10.04 |
Balance Sheet
The company has 192.31 million in cash and 41.04 million in debt, giving a net cash position of 151.27 million or 0.90 per share.
| Cash & Cash Equivalents | 192.31M |
| Total Debt | 41.04M |
| Net Cash | 151.27M |
| Net Cash Per Share | 0.90 |
| Equity (Book Value) | 8.68B |
| Book Value Per Share | 51.82 |
| Working Capital | 2.37B |
Cash Flow
| Operating Cash Flow | 366.04M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IST:SURGY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.29% |
| Shareholder Yield | n/a |
| Earnings Yield | 21.85% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |